In Vivo Evaluation of NM441, a New Thiazeto-Quinoline Derivative
AUTOR(ES)
Ozaki, Masakuni
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=187824Documentos Relacionados
- In Vivo Evaluation of NM441, a New Thiazeto-Quinoline Derivative
- In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
- Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
- In Vitro and In Vivo Evaluation of Ceftezole, a New Cephalosporin Derivative
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.